Interleukin-12: Potential Clinical Applications in the Treatment and Prevention of Infectious Diseases
- 1 January 1996
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 52 (2) , 18-26
- https://doi.org/10.2165/00003495-199600522-00005
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- IL12 receptors and receptor antagonistsResearch in Immunology, 1995
- Interleukin‐12 profoundly up‐regulates the synthesis of antigen‐specific complement‐fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivoEuropean Journal of Immunology, 1995
- Interleukin‐12 is required for interferon‐γ production and lethality in lipopolysaccharide‐induced shock in miceEuropean Journal of Immunology, 1995
- The Th1–Th2 hypothesis of HIV infection: new insightsImmunology Today, 1994
- Multiple Effects on Peripheral Hematology Following Administration of Recombinant Human Interleukin 12 to Nonhuman PrimatesBiochemical and Biophysical Research Communications, 1994
- Interleukin 12 at the site of disease in tuberculosis.Journal of Clinical Investigation, 1994
- Development of T H 1 CD4 + T Cells Through IL-12 Produced by Listeria -Induced MacrophagesScience, 1993
- IL-12: Initiation Cytokine for Cell-Mediated ImmunityScience, 1993
- Assignment of genes encoding a unique cytokine (IL12) composed of two unrelated subunits to chromosomes 3 and 5Genomics, 1992
- Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients.The Journal of Experimental Medicine, 1992